LIPO Lipella Pharmaceuticals Inc
1,020
$0.751
$0.0114
(1.50%)
| Watchers | 1,020 |
| 52-Wk Low | $0.64 |
| 52-Wk High | $2.71 |
| Market Cap | $5.71M |
| Volume | 56,290.00 |
| 52-Wk High | $2.71 |
| 52-Wk Low | $0.64 |
Lipella Pharmaceuticals to Publish Abstract Detailing Compelling Preclinical Support for New Product Candidate at ASCO 2024Globe Newswire • about 1 month ago
PITTSBURGH, April 05, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) ( Lipella, our , us or the Company ), a clinical-stage biotechnology company addressing serious...
Share to Feed
Chief Medical Officer Dr. Michael Chancellor will discuss hemorrhagic cystitis and the company's lead candidate, LP-10PITTSBURGH, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc...
Lipella Pharmaceuticals Inc. (NASDAQ:LIPO Get Free Report)s share price rose 2.9% during trading on Friday . The stock traded as high as $1.07 and last traded at $1.05. Approximately...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Lipella Pharmaceuticals Inc. (NASDAQ:LIPO Get Free Report)s stock price rose 10.3% during mid-day trading on Thursday . The stock traded as high as $1.12 and last traded at $1.09...